SBRA PE Ratio & Valuation,Is SBRA Overvalued

SBRA Relative Valuation

SBRA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SBRA is overvalued; if below, it's undervalued.

Historical Valuation

Sabra Health Care REIT Inc (SBRA) is now in the Fair zone, suggesting that its current forward PS ratio of 5.76 is considered Fairly compared with the five-year average of 27.39. The fair price of Sabra Health Care REIT Inc (SBRA) is between 16.10 to 19.84 according to relative valuation methord.

Relative Value

Fair Zone

16.10-19.84

Current Price：19.16

Fair

26.90

14.31

EV/EBITDA

Sabra Health Care REIT Inc. (SBRA) has a current EV/EBITDA of 14.31. The 5-year average EV/EBITDA is 13.27. The thresholds are as follows: Strongly Undervalued below 11.28, Undervalued between 11.28 and 12.28, Fairly Valued between 14.26 and 12.28, Overvalued between 14.26 and 15.26, and Strongly Overvalued above 15.26. The current Forward EV/EBITDA of 14.31 falls within the Overvalued range.

24.27

EV/EBIT

Sabra Health Care REIT Inc. (SBRA) has a current EV/EBIT of 24.27. The 5-year average EV/EBIT is 21.20. The thresholds are as follows: Strongly Undervalued below 15.91, Undervalued between 15.91 and 18.55, Fairly Valued between 23.84 and 18.55, Overvalued between 23.84 and 26.48, and Strongly Overvalued above 26.48. The current Forward EV/EBIT of 24.27 falls within the Overvalued range.

5.76

Sabra Health Care REIT Inc. (SBRA) has a current PS of 5.76. The 5-year average PS is 5.25. The thresholds are as follows: Strongly Undervalued below 3.85, Undervalued between 3.85 and 4.55, Fairly Valued between 5.96 and 4.55, Overvalued between 5.96 and 6.66, and Strongly Overvalued above 6.66. The current Forward PS of 5.76 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

Sabra Health Care REIT Inc. (SBRA) has a current P/OCF of 0.00. The 5-year average P/OCF is 5.22. The thresholds are as follows: Strongly Undervalued below -3.54, Undervalued between -3.54 and 0.84, Fairly Valued between 9.60 and 0.84, Overvalued between 9.60 and 13.98, and Strongly Overvalued above 13.98. The current Forward P/OCF of 0.00 falls within the Undervalued range.

0.00

P/FCF

Sabra Health Care REIT Inc. (SBRA) has a current P/FCF of 0.00. The 5-year average P/FCF is 1.38. The thresholds are as follows: Strongly Undervalued below -4.43, Undervalued between -4.43 and -1.52, Fairly Valued between 4.29 and -1.52, Overvalued between 4.29 and 7.20, and Strongly Overvalued above 7.20. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

Sabra Health Care REIT Inc (SBRA) has a current Price-to-Book (P/B) ratio of 1.69. Compared to its 3-year average P/B ratio of 1.29 , the current P/B ratio is approximately 31.49% higher. Relative to its 5-year average P/B ratio of 1.17, the current P/B ratio is about 44.26% higher. Sabra Health Care REIT Inc (SBRA) has a Forward Free Cash Flow (FCF) yield of approximately 7.13%. Compared to its 3-year average FCF yield of 8.92%, the current FCF yield is approximately -20.01% lower. Relative to its 5-year average FCF yield of 9.52% , the current FCF yield is about -25.04% lower.

1.69

P/B

Median3y

1.29

Median5y

1.17

7.13

FCF Yield

Median3y

8.92

Median5y

9.52

Competitors Valuation Multiple

The average P/S ratio for SBRA's competitors is , providing a benchmark for relative valuation. Sabra Health Care REIT Inc Corp (SBRA) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 6.76%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of SBRA increased by 14.79% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 19.21 to 26.36.

The secondary factor is the Revenue Growth, contributed 6.76%to the performance.

Overall, the performance of SBRA in the past 1 year is driven by P/E Change. Which is more unsustainable.

6.76%

178.00M → 190.04M

Revenue Growth

-29.17%

16.73 → 11.85

Margin Expansion

37.20%

19.21 → 26.36

P/E Change

14.79%

16.72 → 19.20

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Sabra Health Care REIT Inc (SBRA) currently overvalued or undervalued?

What is Sabra Health Care REIT Inc (SBRA) fair value?

SBRA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Sabra Health Care REIT Inc (SBRA) is between 16.10 to 19.84 according to relative valuation methord.

How does SBRA's valuation metrics compare to the industry average?

What is the current P/B ratio for Sabra Health Care REIT Inc (SBRA) as of Dec 16 2025?

As of Dec 16 2025, Sabra Health Care REIT Inc (SBRA) has a P/B ratio of 1.69. This indicates that the market values SBRA at 1.69 times its book value.

What is the current FCF Yield for Sabra Health Care REIT Inc (SBRA) as of Dec 16 2025?

As of Dec 16 2025, Sabra Health Care REIT Inc (SBRA) has a FCF Yield of 7.13%. This means that for every dollar of Sabra Health Care REIT Inc’s market capitalization, the company generates 7.13 cents in free cash flow.

What is the current Forward P/E ratio for Sabra Health Care REIT Inc (SBRA) as of Dec 16 2025?

As of Dec 16 2025, Sabra Health Care REIT Inc (SBRA) has a Forward P/E ratio of 26.88. This means the market is willing to pay $26.88 for every dollar of Sabra Health Care REIT Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Sabra Health Care REIT Inc (SBRA) as of Dec 16 2025?

As of Dec 16 2025, Sabra Health Care REIT Inc (SBRA) has a Forward P/S ratio of 5.76. This means the market is valuing SBRA at $5.76 for every dollar of expected revenue over the next 12 months.

SBRA Valuation